Self-administered insolvency, three of five sites loss-making

A sterile processing provider entered self-administered insolvency. Three of its five sites were loss-making, energy costs had tripled within eighteen months, and two hospital groups had terminated their contracts with effect from year end. The trustee required a decision on continuation or wind-down within eight weeks.

We modelled each site individually — utilisation, energy consumption per sterile unit, contract terms, staffing structure. Two sites were not viable even at full utilisation. For the remaining three we prepared an asset deal and ran an investor process: eleven parties approached, four submitted bids.

Asset deal with a strategic buyer at EUR 6.8m. Of 241 jobs, 186 were retained — 77 %. Two sites were closed; the remaining three continued under the new owner.